My bookmarksSign up free

Commission Implementing Regulation (EU) 2015/150 of 30 January 2015 amending the Annex to Regulation (EU) No 37/2010 as regards the substance ‘gamithromycin’ Text with EEA relevance

Commission Implementing Regulation (EU) 2015/150 of 30 January 2015 amending the Annex to Regulation (EU) No 37/2010 as regards the substance ‘gamithromycin’ Text with EEA relevance

Implementing Regulation (EU) 2015/150 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union . It shall apply from 1 April 2015.

Supplementary provisions

ANNEXSupplementary provisions

ANNEX In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ‘gamithromycin’ is replaced by the following: Pharmacologically active Substance Marker residue Animal Species MRLs Target Tissues Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic Classification ‘Gamithromycin Gamithromycin Porcine 100 μg/kg Muscle NO ENTRY Anti-infectious agents/Antibiotics’ 100 μg/kg Skin and fat in natural proportions 100 μg/kg Liver 300 μg/kg Kidney Bovine 20 μg/kg Fat Not for use in animals producing milk for human consumption. 200 μg/kg Liver 100 μg/kg Kidney

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next